Inhibitor incidence in haemophilia A under exclusive use of a third-generation recombinant factor VIII concentrate: results of the HEMFIL Cohort Study

on the behalf of the HEMFIL Study Group

Research output: Contribution to journalComment/Letter to the editorAcademic

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)152-155
Number of pages4
JournalBritish journal of haematology
Volume186
Issue number1
DOIs
Publication statusPublished - 1 Jul 2019
Externally publishedYes

Keywords

  • ADVATE
  • haemophilia
  • incidence
  • inhibitor

Cite this